Ondra Martin M.Sc.
Doctoral training
Development and validation of luminescent HTS tool for discovery and optimization of novel combination of CFTR correctors and modifiers
Cystic fibrosis (CF) disease results from mutations in the CFTR gene that encodes for an epithelial membrane protein acting as a chloride ion channel and water transport regulator. The mutations affecting CFTR protein expression result in difficulties in processing, folding, function and/or trafficking to the membrane depending on the type of mutations. Future discoveries of CFTR modulators and correctors rely on screening many chemical libraries. To develop such a screening tool suitable for high-throughput screening (HTS), a cellular model based on the combination of CRISPR/Cas9 technology and HiBiT tag will be prepared.
About me
I am a researcher at the Faculty of Medicine and Dentistry, Palacky University Olomouc, and a Ph.D. candidate in the field of molecular biology and experimental medicine. My interests revolve around the strategic research and development of novel high-throughput screening tools. My research focuses on developing new HTS methods for drug discovery to treat various chronic diseases.
Journals
Books & book chapters
Intellectual property
- Patent: CZ 309422; Granted: 28.12.2022; Ownership: Institute of Organic Chemistry and Biochemistry CAS, Palacky University Olomouc; Inventors: Hajdúch Marián, Jaworek Hana, Ondra Martin, Kubíčková Agáta
- Published Application PCT/CZ2021/050103 under WO 2022/068982 (7.4.2022)
Status: Available
Utility Model: CZ 34808; Granted: 10.2.2021; Ownership: Institute of Organic Chemistry and Biochemistry CAS, Palacky University Olomouc; Inventors: Hajdúch Marián, Jaworek Hana, Ondra Martin, Kubíčková Agáta
Status: Available
Master mentorship
Lenart Lukáš M.Sc.
CRISPR/Cas9 as a tool for the development of a cystic fibrosis model for high throughput screening of compounds